$IVR Income Statement | Understand Stock

$IVR

$5.52 -$0.01 (0.18%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Mortgage-backed and other securities
Commercial loan
Interest income
Secured loans
Interest expense
Net interest income
Other income (loss)
Gain (loss) on investments, net
(Increase) decrease in provision for credit losses
Equity in earnings (losses) of unconsolidated ventures
Gain (loss) on derivative instruments, net
Realized and unrealized credit derivative income (loss), net
Net gain (loss) on extinguishment of debt
Other investment income (loss), net
Total other income (loss)

Expenses
Management fee — related party
General and administrative
Total expenses
Net income (loss)
Dividends to preferred stockholders
Gain (loss) on repurchase and retirement of preferred stock
Issuance and redemption costs of redeemed preferred stock
Net income (loss) attributable to common stockholders
Earnings (loss) per share:
Net income (loss) attributable to common stockholders
Basic (in usd per share)
Diluted (in usd per share)
Weighted average number of shares of common stock:
Basic (in shares)
Diluted (in shares)

Comments